Veeva Systems (VEEV) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...

Veeva Systems (NYSE:VEEV), a provider of cloud solutions for the life sciences sector, reported fiscal 2025 fourth-quarter earnings on Wednesday, March 5, that topped analysts' consensus ...

Wide-moat Veeva reported solid fourth-quarter results that came in slightly ahead of our forecasts. Total sales of $720 million grew 14% year over year, driven by strong performance in both the ...

"Together with Veeva, Boehringer has advanced its approach to clinical trials and is fulfilling our pledge to accelerate the delivery of innovative, life-transforming treatments to patients across ...

London, UK — 11 March 2025 — Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer’s One Medicine Platform, powered by the successful implementation of ...